High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia - Wikidata - awgldk - TriplyDB

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

http://www.wikidata.org/entity/Q34769839

about

Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia.Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational database Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa Factors associated with the failure of first and second-line antiretroviral therapies therapy, a case control study in Cambodian HIV-1 infected children.Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings.HIV treatment and care in resource-constrained environments: challenges for the next decade.Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines.Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients.Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study.Adherence to PI-based 2nd line regimens in Cambodia is not simply a question of individual behaviour: the ANRS 12276 2PICAM study.Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysi Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.

P2860

Q28542625-C8E2681D-C62E-4F89-88AF-A8F283566CA8 Q28545183-68C4952C-7A3D-498A-B95F-6E87D8846F71 Q33914820-6F691A5E-6AF6-4EA3-8EE8-942667F2D674 Q34977431-C6F684BF-65BC-4C99-BBD6-FC1E149084FD Q34998736-5FFB4F9B-9A9E-4DE4-939A-1DE0F1E0EBFE Q35853812-46257BAB-4265-4D4C-8A10-C88AE46C42B2 Q35916294-EE74EE63-03CF-4EB7-AF97-3CE14CAFC669 Q36118338-BBAF6A49-CA7F-42D3-9797-F46889C952D7 Q36157484-7476C2A7-CB34-42C7-9D3C-BBB94564E389 Q36386806-734D3674-EF3D-4C0E-8959-C6CF796A449A Q36460759-5BC5557D-1233-4503-993A-EF20AAB170C8 Q36647012-8592007B-4A77-49F3-ADE3-B054390D3730 Q36937877-0B19827F-9C0D-4787-9AD9-23A1DAA5B780 Q37003942-5696DA78-EC39-4CC5-9396-354D0872E01C Q37330773-85D74DD8-1D0A-4F18-B484-38D747D49618 Q37516995-BBFC3C37-28B0-4E9C-A6DD-916B7E1F3DBC Q40041832-A1D2FD0C-A5ED-4C62-AE17-61C2C060C357 Q47258937-1D06F1CE-A21C-434B-8483-8ECB3FE9311E Q53694767-EAAEF155-57B6-44A1-A57C-4F6D9156DBB3

P2860

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

http://www.wikidata.org/entity/Q34769839

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@ast

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@en

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@nl

type

label

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@ast

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@en

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@nl

prefLabel

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@ast

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@en

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@nl

P1433

Q34769839-B1959B81-0B10-466C-BD9A-6C8CE5F669E4

P1476

Q34769839-AAD9A072-1B1A-420F-8AC2-4B5FBC50851C

P2093

Q34769839-0B86A76C-B2C4-4683-8685-31DD1B28DB19

Q34769839-271395FD-D25E-439F-9EB6-B29360557787

Q34769839-311635E6-3A0E-4C7E-9942-CBB6A9AED10C

Q34769839-3DBCE241-CC16-4A8C-B529-029FC6EB227D

Q34769839-62093785-0062-48BD-8225-31DAB9A259BA

Q34769839-71330CC8-D3C2-4095-B207-56ADCF526267

Q34769839-7C71E82D-5A43-4AFA-83FD-050F1E892BFB

Q34769839-D709FA78-C60B-4A42-AD86-B2B466B6489D

Q34769839-D71CC227-AD59-486D-AA16-872DC8244530

Q34769839-E21F4B4C-B236-43D9-8628-BFBB783779A6

P2860

Q34769839-09A24F45-B461-472B-865A-7F30F17E7E08

Q34769839-10710A61-F7E2-4FFE-BF78-DBD2ABDC1CB2

Q34769839-10C6C337-E621-4EB9-9AA4-ABA70BD2E905

Q34769839-1D778D57-C868-45DF-B004-B024B1CC4260

Q34769839-1E4A5327-36C0-484B-936A-1B0EC59F3BBA

Q34769839-1EF7AC67-1EF7-40FA-8BB4-CCBFA6961803

Q34769839-313B425D-B194-48AA-A3A7-06D50289CD6A

Q34769839-318BEA5F-C0A1-4E70-B29A-3F82B9ED6A3B

Q34769839-3CCE6D83-B540-49FA-89DF-CD51D517E058

Q34769839-41054B41-0FAC-4F34-9F36-AC0DC59DAF46

P2888

Q34769839-5D301231-675A-4295-97CB-528B9B67CB80

P304

Q34769839-7D9BCC61-A416-4D55-879D-82D20891022A

P31

Q34769839-B7C99AB0-A5EE-4353-B400-EF5CD76ECFF1

P356

Q34769839-334EBEE4-5716-4A03-BA74-94C3780D24C9

P478

Q34769839-7468FC5F-60F9-40D6-AE03-3B77EB5C5B1A

P50

Q34769839-1B0DCD18-05C0-44D3-8785-8D43663B32E1

Q34769839-A698004C-95B6-403D-827D-5361B6920369

P577

Q34769839-7F62D9D2-EDEB-4975-B63D-2DEFAB384655

P5875

Q34769839-C9036498-0983-450A-B9FD-4083F3A9CDE0

P6179

Q34769839-9265D455-EB65-48EC-B5EB-2B1E428246AB

P698

Q34769839-3AA18EF8-BC33-434E-9764-8D8103CF4374

P921

Q34769839-325C0DD8-4413-4948-A077-BFE769FDD86D

Q34769839-CF9DD301-055F-40DE-9074-8ED46955D9E4

P932

Q34769839-D7AB8B0A-0376-46CE-ACB9-92B9AD07B531

P356

1758-2652-14-14

P1433

Journal of the International AIDS Society

P1476

High efficacy of lopinavir/r-b ...... spital in Phnom Penh, Cambodia

@en

P2093

Anne Dulioust

http://www.w3.org/2001/XMLSchema#string

Chanroeurn Hak

http://www.w3.org/2001/XMLSchema#string

Chhi Vun Mean

http://www.w3.org/2001/XMLSchema#string

Isabelle Fournier

http://www.w3.org/2001/XMLSchema#string

Janin Nouhin

http://www.w3.org/2001/XMLSchema#string

Jean-François Delfraissy

http://www.w3.org/2001/XMLSchema#string

Laurent Ferradini

http://www.w3.org/2001/XMLSchema#string

Nathalie Lerolle

http://www.w3.org/2001/XMLSchema#string

Olivier Segeral

http://www.w3.org/2001/XMLSchema#string

Sopheak Ngin

http://www.w3.org/2001/XMLSchema#string

P2860

Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research.

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.

Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation.

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa.

P2888

1758-2652-14-14

P304

14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1758-2652-14-14

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Jean-François Delfraissy

P577

2011-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50865569

http://www.w3.org/2001/XMLSchema#string

P6179

1003691018

http://www.w3.org/2001/XMLSchema#string

P698

21439074

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3072300

http://www.w3.org/2001/XMLSchema#string